We are excited to share that DaeSeong Im, our Chief Technology Officer (CTO), invited to the Australia Biologics Festival (ABF) 2023, hosted by IMPAC in Melbourne from February 28 to March 01, 2023. During the event, he presented an engaging talk about our innovative multi-target platform, UniStac®, as well as our current pipelines for NASH/Fibrosis and Immuno-oncology.
This prominent gathering offered a unique opportunity to explore potential collaborations, technologies, services, strategies, and more, for successful manufacturing.